119 related articles for article (PubMed ID: 2119910)
1. Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CF1 mouse.
Bauer-Hofmann R; Buchmann A; Wright AS; Schwarz M
Carcinogenesis; 1990 Oct; 11(10):1875-7. PubMed ID: 2119910
[TBL] [Abstract][Full Text] [Related]
2. Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse.
Buchmann A; Mahr J; Bauer-Hofmann R; Schwarz M
Mol Carcinog; 1989; 2(3):121-5. PubMed ID: 2675901
[TBL] [Abstract][Full Text] [Related]
3. The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice.
Bauer-Hofmann R; Buchmann A; Mahr J; Kress S; Schwarz M
Carcinogenesis; 1992 Mar; 13(3):477-81. PubMed ID: 1312398
[TBL] [Abstract][Full Text] [Related]
4. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.
Devereux TR; Foley JF; Maronpot RR; Kari F; Anderson MW
Carcinogenesis; 1993 May; 14(5):795-801. PubMed ID: 8504471
[TBL] [Abstract][Full Text] [Related]
5. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.
Buchmann A; Bauer-Hofmann R; Mahr J; Drinkwater NR; Luz A; Schwarz M
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):911-5. PubMed ID: 1992483
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
Rumsby PC; Barrass NC; Phillimore HE; Evans JG
Carcinogenesis; 1991 Dec; 12(12):2331-6. PubMed ID: 1747936
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice.
Stanley LA; Devereux TR; Foley J; Lord PG; Maronpot RR; Orton TC; Anderson MW
Carcinogenesis; 1992 Dec; 13(12):2427-33. PubMed ID: 1361883
[TBL] [Abstract][Full Text] [Related]
8. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.
McMahon G; Davis EF; Huber LJ; Kim Y; Wogan GN
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1104-8. PubMed ID: 2105496
[TBL] [Abstract][Full Text] [Related]
9. Point mutation analysis of ras genes in spontaneous and chemically induced C57Bl/10J mouse liver tumours.
Lord PG; Hardaker KJ; Loughlin JM; Marsden AM; Orton TC
Carcinogenesis; 1992 Aug; 13(8):1383-7. PubMed ID: 1499088
[TBL] [Abstract][Full Text] [Related]
10. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
11. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
[TBL] [Abstract][Full Text] [Related]
12. In vitro activation of the human Harvey-ras proto-oncogene by aflatoxin B1.
Riley J; Mandel HG; Sinha S; Judah DJ; Neal GE
Carcinogenesis; 1997 May; 18(5):905-10. PubMed ID: 9163674
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.
Fox TR; Schumann AM; Watanabe PG; Yano BL; Maher VM; McCormick JJ
Cancer Res; 1990 Jul; 50(13):4014-9. PubMed ID: 2191770
[TBL] [Abstract][Full Text] [Related]
14. Ras mutations in methylclofenapate-induced B6C3F1 and C57BL/10J mouse liver tumours.
Stanley LA; Blackburn DR; Devereaux S; Foley J; Lord PG; Maronpot RR; Orton TC; Anderson MW
Carcinogenesis; 1994 Jun; 15(6):1125-31. PubMed ID: 8020144
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ras gene mutations in rainbow trout liver tumors initiated by aflatoxin B1.
Chang YJ; Mathews C; Mangold K; Marien K; Hendricks J; Bailey G
Mol Carcinog; 1991; 4(2):112-9. PubMed ID: 1645972
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
[TBL] [Abstract][Full Text] [Related]
17. Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors.
Manam S; Shinder GA; Joslyn DJ; Kraynak AR; Hammermeister CL; Leander KR; Ledwith BJ; Prahalada S; van Zwieten MJ; Nichols WW
Carcinogenesis; 1995 May; 16(5):1113-9. PubMed ID: 7767973
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986.
Richardson KK; Helvering LM; Copple DM; Rexroat MA; Linville DW; Engelhardt JA; Todd GC; Richardson FC
Carcinogenesis; 1992 Jun; 13(6):935-41. PubMed ID: 1350949
[TBL] [Abstract][Full Text] [Related]
20. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.
Dragani TA; Manenti G; Colombo BM; Falvella FS; Gariboldi M; Pierotti MA; Della Porta G
Oncogene; 1991 Feb; 6(2):333-8. PubMed ID: 2000226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
